Full View

An integrative model of pathway convergence in genetically heterogeneous blast crisis chronic myeloid leukemia

TK Ko, A Javed, KL Lee, TN Pathiraja… - Blood, The Journal …, 2020 - ashpublications.org
Targeted therapies against the BCR-ABL1 kinase have revolutionized treatment of chronic
phase (CP) chronic myeloid leukemia (CML). In contrast, management of blast crisis (BC) …
被引用次数：59 相关文章

An integrative model of pathway convergence in genetically heterogeneous blast crisis chronic myeloid leukemia.

TK Ko, A Javed, KL Lee, TN Pathiraja, X Liu, S Malik… - Blood, 2020 - europepmc.org
Targeted therapies against the BCR-ABL1 kinase have revolutionized treatment of chronic
phase (CP) chronic myeloid leukemia (CML). In contrast, management of blast crisis (BC) …

An integrative model of pathway convergence in genetically heterogeneous blast crisis chronic myeloid leukemia

TK Kiat, A Javed, KL Leong, TN Pathiraja, X LIU… - Blood, 2020 - hub.hku.hk
Targeted therapies against the BCR-ABL1 kinase have revolutionized treatment of chronic
phase (CP) chronic myeloid leukemia (CML). In contrast, management of blast crisis (BC) …
[HTML] sciencedirect.com

[HTML][HTML] An integrative model of pathway convergence in genetically heterogeneous blast crisis chronic myeloid leukemia

TK Ko, A Javed, KL Lee, TN Pathiraja, X Liu, S Malik… - Blood, 2020 - Elsevier
Targeted therapies against the BCR-ABL1 kinase have revolutionized treatment of chronic
phase (CP) chronic myeloid leukemia (CML). In contrast, management of blast crisis (BC) …

An integrative model of pathway convergence in genetically heterogeneous blast crisis chronic myeloid leukemia

TK Ko, A Javed, KL Lee, TN Pathiraja, X Liu, S Malik… - Blood, 2020 - kups.ub.uni-koeln.de
Targeted therapies against the BCR-ABL1 kinase have revolutionized treatment of chronic
phase (CP) chronic myeloid leukemia (CML). In contrast, management of blast crisis (BC) …

An integrative model of pathway convergence in genetically heterogeneous blast crisis chronic myeloid leukemia

TK Ko, A Javed, KL Lee, TN Pathiraja, X Liu, S Malik… - Blood, 2020 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Targeted therapies against the BCR-ABL1
kinase have revolutionized treatment of chronic phase (CP) chronic myeloid leukemia …

An integrative model of pathway convergence in genetically heterogeneous blast crisis chronic myeloid leukemia

TK Ko, A Javed, KL Lee, TN Pathiraja, X Liu… - …, 2020 - pubmed.ncbi.nlm.nih.gov
Targeted therapies against the BCR-ABL1 kinase have revolutionized treatment of chronic
phase (CP) chronic myeloid leukemia (CML). In contrast, management of blast crisis (BC) …

An integrative model of pathway convergence in genetically heterogeneous blast crisis chronic myeloid leukemia

TK Ko, A Javed, KL Lee, TN Pathiraja, X Liu, S Malik… - Blood, 2020 - kups.ub.uni-koeln.de
Targeted therapies against the BCR-ABL1 kinase have revolutionized treatment of chronic
phase (CP) chronic myeloid leukemia (CML). In contrast, management of blast crisis (BC) …